Alps Advisors Inc. Buys 17,832 Shares of Encompass Health Corporation (NYSE:EHC)

Alps Advisors Inc. increased its holdings in Encompass Health Corporation (NYSE:EHC - Free Report) by 9.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 200,462 shares of the company's stock after purchasing an additional 17,832 shares during the quarter. Alps Advisors Inc. owned approximately 0.20% of Encompass Health worth $20,303,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of the business. Colonial Trust Co SC bought a new stake in shares of Encompass Health during the fourth quarter valued at approximately $29,000. Transce3nd LLC bought a new stake in shares of Encompass Health during the 4th quarter valued at $40,000. CBIZ Investment Advisory Services LLC grew its position in shares of Encompass Health by 38.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock valued at $42,000 after acquiring an additional 127 shares during the period. Signaturefd LLC boosted its holdings in Encompass Health by 21.6% in the 4th quarter. Signaturefd LLC now owns 704 shares of the company's stock worth $65,000 after buying an additional 125 shares during the period. Finally, Arlington Trust Co LLC boosted its holdings in Encompass Health by 22.9% in the 1st quarter. Arlington Trust Co LLC now owns 671 shares of the company's stock worth $68,000 after buying an additional 125 shares during the period. 97.25% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

EHC has been the topic of several recent research reports. Barclays upped their target price on shares of Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a research report on Friday, April 25th. UBS Group raised their target price on shares of Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a research report on Monday, April 28th. Royal Bank Of Canada increased their price objective on shares of Encompass Health from $110.00 to $125.00 and gave the company an "outperform" rating in a research note on Monday, April 28th. Stephens upgraded shares of Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 target price for the company in a research note on Thursday, June 5th. Finally, KeyCorp lifted their price objective on shares of Encompass Health from $122.00 to $135.00 and gave the stock an "overweight" rating in a research note on Tuesday, May 27th. Seven equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, Encompass Health has a consensus rating of "Buy" and a consensus target price of $131.50.

Insider Buying and Selling

In other news, CEO Mark J. Tarr sold 118,384 shares of the stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $121.53, for a total value of $14,387,207.52. Following the completion of the sale, the chief executive officer owned 527,070 shares of the company's stock, valued at $64,054,817.10. This represents a 18.34% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP John Patrick Darby sold 10,000 shares of the company's stock in a transaction on Tuesday, April 29th. The shares were sold at an average price of $114.79, for a total transaction of $1,147,900.00. Following the completion of the transaction, the executive vice president owned 79,710 shares of the company's stock, valued at $9,149,910.90. This trade represents a 11.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 132,663 shares of company stock valued at $16,034,082. Insiders own 2.00% of the company's stock.

Encompass Health Price Performance

Shares of NYSE:EHC opened at $117.58 on Friday. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.06 and a quick ratio of 1.06. Encompass Health Corporation has a 12 month low of $82.74 and a 12 month high of $123.13. The firm has a market capitalization of $11.85 billion, a P/E ratio of 24.29, a P/E/G ratio of 2.39 and a beta of 0.88. The company's fifty day moving average price is $119.54 and its 200 day moving average price is $106.03.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings data on Thursday, April 24th. The company reported $1.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.19 by $0.18. The company had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. Encompass Health had a net margin of 8.97% and a return on equity of 17.63%. Encompass Health's revenue for the quarter was up 10.6% on a year-over-year basis. During the same period last year, the firm posted $1.12 EPS. As a group, sell-side analysts predict that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 0.58%. The ex-dividend date is Tuesday, July 1st. Encompass Health's dividend payout ratio (DPR) is 14.05%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.